CGON - CIK 0001991792
CG Oncology, Inc. (CGON) reported net income of -$161.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$161.00M | -82.9% |
| FY 2024 | -$88.04M | -81.1% |
| FY 2023 | -$48.61M | - |
CG Oncology, Inc. (CGON) reported net income of -$161.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.